Archief Roodbont

Anthony is the Co-Director of the Clinical Trials Research Unit, at The University of Auckland. He has a decade of research experience in the design, conduct and analysis of large studies of the causes, prevention and treatment of cardiovascular disease. Anthony helped co-ordinate the largest ever surgical trial, testing aspirin in the prevention of deep vein thrombosis and pulmonary embolism and involving over 17,000 patients from Australasia, South Africa and Europe. Anthony also helped design and run the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) involving over 6000 patients from Australasia, Asia and Europe and a collaboration of more than 50 cohort studies in the Asia Pacific, involving more than 600,000 participants, that assesses the determinants of cardiovascular disease in the region.

Most recently, Anthony was the Principal Author of the 2002 World Health Report entitled "Reducing risks, promoting healthy life". The report assessed burden of disease due to a wide range of risks to health around the globe, and evaluated relevant interventions and policy options. The World Health Report is the main annual publication of the World Health Organisation.

Anthony graduated in medicine in the United Kingdom and trained in epidemiology and public health in New Zealand, gaining a Diploma of Public Health and a PhD at the University of Auckland and becoming a Fellow of the Australasian Faculty of Public Health Medicine. Anthony is a member of the Data and Safety Monitoring Board of the Health Research Council, and the Large Scale Clinical Trials Committee of the National Health and Medical Research Council of Australia. He is regularly invited to give presentations at national and international conferences.

• Accessibility
• Contact us
• Copy